nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—ulcerative colitis—colon cancer	0.567	1	CtDrD
Triamcinolone—PTGS2—colon cancer	0.272	1	CbGaD
Triamcinolone—BCHE—Irinotecan—colon cancer	0.0616	0.778	CbGbCtD
Triamcinolone—CYP3A4—Irinotecan—colon cancer	0.00937	0.118	CbGbCtD
Triamcinolone—CYP3A4—Vincristine—colon cancer	0.00819	0.103	CbGbCtD
Triamcinolone—SERPINA6—renal system—colon cancer	0.000725	0.0669	CbGeAlD
Triamcinolone—PTGS2—endothelium—colon cancer	0.00066	0.0609	CbGeAlD
Triamcinolone—PTGS2—blood vessel—colon cancer	0.000608	0.0562	CbGeAlD
Triamcinolone—PTGS2—gall bladder—colon cancer	0.000572	0.0528	CbGeAlD
Triamcinolone—SERPINA6—bone marrow—colon cancer	0.000548	0.0506	CbGeAlD
Triamcinolone—SERPINA6—liver—colon cancer	0.000443	0.0409	CbGeAlD
Triamcinolone—Throat sore—Capecitabine—colon cancer	0.000424	0.00599	CcSEcCtD
Triamcinolone—Blister—Capecitabine—colon cancer	0.000424	0.00599	CcSEcCtD
Triamcinolone—Oropharyngeal discomfort—Capecitabine—colon cancer	0.00042	0.00594	CcSEcCtD
Triamcinolone—NR3C1—embryo—colon cancer	0.000419	0.0387	CbGeAlD
Triamcinolone—Osteoporosis—Methotrexate—colon cancer	0.000406	0.00574	CcSEcCtD
Triamcinolone—Thrombophlebitis—Irinotecan—colon cancer	0.000383	0.00541	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Methotrexate—colon cancer	0.000383	0.00541	CcSEcCtD
Triamcinolone—Euphoric mood—Fluorouracil—colon cancer	0.000376	0.00531	CcSEcCtD
Triamcinolone—Petechiae—Capecitabine—colon cancer	0.000372	0.00525	CcSEcCtD
Triamcinolone—BCHE—smooth muscle tissue—colon cancer	0.00037	0.0342	CbGeAlD
Triamcinolone—Thrombophlebitis—Fluorouracil—colon cancer	0.000367	0.00518	CcSEcCtD
Triamcinolone—PTGS2—embryo—colon cancer	0.000363	0.0335	CbGeAlD
Triamcinolone—Folliculitis—Methotrexate—colon cancer	0.000362	0.00512	CcSEcCtD
Triamcinolone—Injury—Irinotecan—colon cancer	0.000361	0.0051	CcSEcCtD
Triamcinolone—Embolism—Methotrexate—colon cancer	0.000355	0.00501	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Irinotecan—colon cancer	0.000343	0.00484	CcSEcCtD
Triamcinolone—NR3C1—epithelium—colon cancer	0.000342	0.0316	CbGeAlD
Triamcinolone—Oropharyngeal pain—Capecitabine—colon cancer	0.000336	0.00475	CcSEcCtD
Triamcinolone—Dermatitis bullous—Fluorouracil—colon cancer	0.000332	0.0047	CcSEcCtD
Triamcinolone—Osteoarthritis—Irinotecan—colon cancer	0.000332	0.00469	CcSEcCtD
Triamcinolone—NR3C1—smooth muscle tissue—colon cancer	0.00033	0.0304	CbGeAlD
Triamcinolone—Cardiac arrest—Vincristine—colon cancer	0.000324	0.00457	CcSEcCtD
Triamcinolone—Ulcer—Capecitabine—colon cancer	0.000323	0.00457	CcSEcCtD
Triamcinolone—Cataract—Capecitabine—colon cancer	0.000321	0.00454	CcSEcCtD
Triamcinolone—Osteoarthritis—Fluorouracil—colon cancer	0.000318	0.00449	CcSEcCtD
Triamcinolone—NR3C1—renal system—colon cancer	0.000317	0.0293	CbGeAlD
Triamcinolone—Cardiac arrest—Irinotecan—colon cancer	0.000315	0.00446	CcSEcCtD
Triamcinolone—Hiccups—Capecitabine—colon cancer	0.000306	0.00432	CcSEcCtD
Triamcinolone—Cardiac arrest—Fluorouracil—colon cancer	0.000302	0.00427	CcSEcCtD
Triamcinolone—Muscular weakness—Vincristine—colon cancer	0.0003	0.00424	CcSEcCtD
Triamcinolone—PTGS2—epithelium—colon cancer	0.000296	0.0273	CbGeAlD
Triamcinolone—BCHE—digestive system—colon cancer	0.000292	0.027	CbGeAlD
Triamcinolone—Candida infection—Capecitabine—colon cancer	0.000292	0.00412	CcSEcCtD
Triamcinolone—Skin exfoliation—Capecitabine—colon cancer	0.000292	0.00412	CcSEcCtD
Triamcinolone—Fluid retention—Capecitabine—colon cancer	0.00029	0.0041	CcSEcCtD
Triamcinolone—Abdominal distension—Irinotecan—colon cancer	0.000289	0.00408	CcSEcCtD
Triamcinolone—Abscess—Methotrexate—colon cancer	0.000288	0.00406	CcSEcCtD
Triamcinolone—Neuropathy—Capecitabine—colon cancer	0.000287	0.00406	CcSEcCtD
Triamcinolone—PTGS2—smooth muscle tissue—colon cancer	0.000285	0.0263	CbGeAlD
Triamcinolone—Pancreatitis—Irinotecan—colon cancer	0.000281	0.00397	CcSEcCtD
Triamcinolone—Muscular weakness—Fluorouracil—colon cancer	0.00028	0.00396	CcSEcCtD
Triamcinolone—Sweating increased—Irinotecan—colon cancer	0.000279	0.00394	CcSEcCtD
Triamcinolone—Petechiae—Methotrexate—colon cancer	0.000277	0.00391	CcSEcCtD
Triamcinolone—Ecchymosis—Capecitabine—colon cancer	0.000276	0.00391	CcSEcCtD
Triamcinolone—PTGS2—renal system—colon cancer	0.000275	0.0254	CbGeAlD
Triamcinolone—BCHE—bone marrow—colon cancer	0.00027	0.0249	CbGeAlD
Triamcinolone—Upper respiratory tract infection—Irinotecan—colon cancer	0.000266	0.00376	CcSEcCtD
Triamcinolone—NR3C1—lymphoid tissue—colon cancer	0.000264	0.0243	CbGeAlD
Triamcinolone—NR3C1—digestive system—colon cancer	0.00026	0.024	CbGeAlD
Triamcinolone—Acute coronary syndrome—Vincristine—colon cancer	0.000259	0.00365	CcSEcCtD
Triamcinolone—BCHE—vagina—colon cancer	0.000258	0.0238	CbGeAlD
Triamcinolone—Myocardial infarction—Vincristine—colon cancer	0.000257	0.00363	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Vincristine—colon cancer	0.000257	0.00363	CcSEcCtD
Triamcinolone—Thrombophlebitis—Capecitabine—colon cancer	0.000256	0.00362	CcSEcCtD
Triamcinolone—Diabetes mellitus—Capecitabine—colon cancer	0.000255	0.00361	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000255	0.0036	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Irinotecan—colon cancer	0.000252	0.00356	CcSEcCtD
Triamcinolone—Myocardial infarction—Irinotecan—colon cancer	0.000251	0.00354	CcSEcCtD
Triamcinolone—Vascular purpura—Capecitabine—colon cancer	0.000248	0.00351	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Fluorouracil—colon cancer	0.000241	0.00341	CcSEcCtD
Triamcinolone—Ulcer—Methotrexate—colon cancer	0.000241	0.0034	CcSEcCtD
Triamcinolone—CYP3A4—renal system—colon cancer	0.00024	0.0222	CbGeAlD
Triamcinolone—NR3C1—bone marrow—colon cancer	0.00024	0.0221	CbGeAlD
Triamcinolone—Neuropathy peripheral—Fluorouracil—colon cancer	0.00024	0.00339	CcSEcCtD
Triamcinolone—Myocardial infarction—Fluorouracil—colon cancer	0.00024	0.00339	CcSEcCtD
Triamcinolone—Conjunctivitis—Fluorouracil—colon cancer	0.000238	0.00336	CcSEcCtD
Triamcinolone—Increased appetite—Capecitabine—colon cancer	0.000236	0.00334	CcSEcCtD
Triamcinolone—Bradycardia—Irinotecan—colon cancer	0.000234	0.0033	CcSEcCtD
Triamcinolone—Vasculitis—Methotrexate—colon cancer	0.000233	0.00329	CcSEcCtD
Triamcinolone—Dermatitis bullous—Capecitabine—colon cancer	0.000232	0.00328	CcSEcCtD
Triamcinolone—Epistaxis—Fluorouracil—colon cancer	0.000231	0.00326	CcSEcCtD
Triamcinolone—Haemoglobin—Irinotecan—colon cancer	0.000231	0.00326	CcSEcCtD
Triamcinolone—Purpura—Capecitabine—colon cancer	0.00023	0.00325	CcSEcCtD
Triamcinolone—Rhinitis—Irinotecan—colon cancer	0.00023	0.00325	CcSEcCtD
Triamcinolone—NR3C1—vagina—colon cancer	0.00023	0.0212	CbGeAlD
Triamcinolone—Haemorrhage—Irinotecan—colon cancer	0.000229	0.00324	CcSEcCtD
Triamcinolone—PTGS2—lymphoid tissue—colon cancer	0.000228	0.0211	CbGeAlD
Triamcinolone—PTGS2—digestive system—colon cancer	0.000225	0.0208	CbGeAlD
Triamcinolone—Osteoarthritis—Capecitabine—colon cancer	0.000222	0.00314	CcSEcCtD
Triamcinolone—Haemoglobin—Fluorouracil—colon cancer	0.000221	0.00312	CcSEcCtD
Triamcinolone—Rhinitis—Fluorouracil—colon cancer	0.00022	0.00311	CcSEcCtD
Triamcinolone—Haemorrhage—Fluorouracil—colon cancer	0.00022	0.0031	CcSEcCtD
Triamcinolone—Pharyngitis—Fluorouracil—colon cancer	0.000218	0.00308	CcSEcCtD
Triamcinolone—BCHE—liver—colon cancer	0.000218	0.0201	CbGeAlD
Triamcinolone—Skin exfoliation—Methotrexate—colon cancer	0.000217	0.00307	CcSEcCtD
Triamcinolone—Cardiac arrest—Capecitabine—colon cancer	0.000211	0.00298	CcSEcCtD
Triamcinolone—Mood swings—Capecitabine—colon cancer	0.00021	0.00297	CcSEcCtD
Triamcinolone—PTGS2—bone marrow—colon cancer	0.000208	0.0192	CbGeAlD
Triamcinolone—Ecchymosis—Methotrexate—colon cancer	0.000206	0.00291	CcSEcCtD
Triamcinolone—Arrhythmia—Irinotecan—colon cancer	0.000205	0.0029	CcSEcCtD
Triamcinolone—Pulmonary oedema—Methotrexate—colon cancer	0.000203	0.00286	CcSEcCtD
Triamcinolone—PTGS2—vagina—colon cancer	0.000199	0.0184	CbGeAlD
Triamcinolone—Back pain—Vincristine—colon cancer	0.000198	0.0028	CcSEcCtD
Triamcinolone—CYP3A4—digestive system—colon cancer	0.000197	0.0182	CbGeAlD
Triamcinolone—Arrhythmia—Fluorouracil—colon cancer	0.000196	0.00277	CcSEcCtD
Triamcinolone—Muscular weakness—Capecitabine—colon cancer	0.000196	0.00277	CcSEcCtD
Triamcinolone—NR3C1—liver—colon cancer	0.000194	0.0179	CbGeAlD
Triamcinolone—Back pain—Irinotecan—colon cancer	0.000193	0.00273	CcSEcCtD
Triamcinolone—Abdominal distension—Capecitabine—colon cancer	0.000193	0.00273	CcSEcCtD
Triamcinolone—Influenza—Capecitabine—colon cancer	0.000192	0.00271	CcSEcCtD
Triamcinolone—Asthma—Capecitabine—colon cancer	0.000192	0.00271	CcSEcCtD
Triamcinolone—Erythema—Fluorouracil—colon cancer	0.000191	0.0027	CcSEcCtD
Triamcinolone—Thrombophlebitis—Methotrexate—colon cancer	0.000191	0.0027	CcSEcCtD
Triamcinolone—Diabetes mellitus—Methotrexate—colon cancer	0.00019	0.00268	CcSEcCtD
Triamcinolone—Sweating increased—Capecitabine—colon cancer	0.000187	0.00264	CcSEcCtD
Triamcinolone—Ill-defined disorder—Irinotecan—colon cancer	0.000185	0.00262	CcSEcCtD
Triamcinolone—Bronchitis—Capecitabine—colon cancer	0.000184	0.00261	CcSEcCtD
Triamcinolone—Vertigo—Vincristine—colon cancer	0.000184	0.0026	CcSEcCtD
Triamcinolone—Malaise—Irinotecan—colon cancer	0.00018	0.00254	CcSEcCtD
Triamcinolone—Vertigo—Irinotecan—colon cancer	0.000179	0.00254	CcSEcCtD
Triamcinolone—Syncope—Irinotecan—colon cancer	0.000179	0.00253	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Capecitabine—colon cancer	0.000178	0.00252	CcSEcCtD
Triamcinolone—Convulsion—Vincristine—colon cancer	0.000178	0.00251	CcSEcCtD
Triamcinolone—Hypertension—Vincristine—colon cancer	0.000177	0.0025	CcSEcCtD
Triamcinolone—Loss of consciousness—Irinotecan—colon cancer	0.000176	0.00248	CcSEcCtD
Triamcinolone—Myalgia—Vincristine—colon cancer	0.000175	0.00247	CcSEcCtD
Triamcinolone—Weight increased—Capecitabine—colon cancer	0.000175	0.00247	CcSEcCtD
Triamcinolone—Cough—Irinotecan—colon cancer	0.000174	0.00246	CcSEcCtD
Triamcinolone—Hypertension—Irinotecan—colon cancer	0.000172	0.00244	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Methotrexate—colon cancer	0.000171	0.00241	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Capecitabine—colon cancer	0.000169	0.00238	CcSEcCtD
Triamcinolone—Discomfort—Irinotecan—colon cancer	0.000168	0.00237	CcSEcCtD
Triamcinolone—PTGS2—liver—colon cancer	0.000168	0.0155	CbGeAlD
Triamcinolone—Myocardial infarction—Capecitabine—colon cancer	0.000168	0.00237	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Capecitabine—colon cancer	0.000168	0.00237	CcSEcCtD
Triamcinolone—Oedema—Vincristine—colon cancer	0.000167	0.00236	CcSEcCtD
Triamcinolone—Anaphylactic shock—Vincristine—colon cancer	0.000167	0.00236	CcSEcCtD
Triamcinolone—BCHE—lymph node—colon cancer	0.000167	0.0154	CbGeAlD
Triamcinolone—Infection—Vincristine—colon cancer	0.000166	0.00235	CcSEcCtD
Triamcinolone—Conjunctivitis—Capecitabine—colon cancer	0.000166	0.00235	CcSEcCtD
Triamcinolone—Convulsion—Fluorouracil—colon cancer	0.000166	0.00234	CcSEcCtD
Triamcinolone—Osteoarthritis—Methotrexate—colon cancer	0.000165	0.00233	CcSEcCtD
Triamcinolone—Anaphylactic shock—Irinotecan—colon cancer	0.000163	0.0023	CcSEcCtD
Triamcinolone—Oedema—Irinotecan—colon cancer	0.000163	0.0023	CcSEcCtD
Triamcinolone—Myalgia—Fluorouracil—colon cancer	0.000163	0.0023	CcSEcCtD
Triamcinolone—Infection—Irinotecan—colon cancer	0.000162	0.00229	CcSEcCtD
Triamcinolone—Hyperhidrosis—Vincristine—colon cancer	0.000162	0.00229	CcSEcCtD
Triamcinolone—Epistaxis—Capecitabine—colon cancer	0.000161	0.00228	CcSEcCtD
Triamcinolone—Discomfort—Fluorouracil—colon cancer	0.000161	0.00227	CcSEcCtD
Triamcinolone—Shock—Irinotecan—colon cancer	0.00016	0.00227	CcSEcCtD
Triamcinolone—Hyperhidrosis—Irinotecan—colon cancer	0.000158	0.00223	CcSEcCtD
Triamcinolone—Mood swings—Methotrexate—colon cancer	0.000157	0.00221	CcSEcCtD
Triamcinolone—Bradycardia—Capecitabine—colon cancer	0.000156	0.00221	CcSEcCtD
Triamcinolone—Oedema—Fluorouracil—colon cancer	0.000156	0.00221	CcSEcCtD
Triamcinolone—Anaphylactic shock—Fluorouracil—colon cancer	0.000156	0.00221	CcSEcCtD
Triamcinolone—Infection—Fluorouracil—colon cancer	0.000155	0.00219	CcSEcCtD
Triamcinolone—Haemoglobin—Capecitabine—colon cancer	0.000154	0.00218	CcSEcCtD
Triamcinolone—Rhinitis—Capecitabine—colon cancer	0.000154	0.00217	CcSEcCtD
Triamcinolone—Haemorrhage—Capecitabine—colon cancer	0.000154	0.00217	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000152	0.00215	CcSEcCtD
Triamcinolone—Pharyngitis—Capecitabine—colon cancer	0.000152	0.00215	CcSEcCtD
Triamcinolone—Tachycardia—Fluorouracil—colon cancer	0.000152	0.00215	CcSEcCtD
Triamcinolone—Insomnia—Vincristine—colon cancer	0.000151	0.00214	CcSEcCtD
Triamcinolone—Fluticasone furoate—ABCB1—colon cancer	0.000151	0.189	CrCbGaD
Triamcinolone—Paraesthesia—Vincristine—colon cancer	0.00015	0.00212	CcSEcCtD
Triamcinolone—NR3C1—lymph node—colon cancer	0.000149	0.0137	CbGeAlD
Triamcinolone—Insomnia—Irinotecan—colon cancer	0.000147	0.00208	CcSEcCtD
Triamcinolone—CYP3A4—liver—colon cancer	0.000147	0.0135	CbGeAlD
Triamcinolone—Paraesthesia—Irinotecan—colon cancer	0.000146	0.00207	CcSEcCtD
Triamcinolone—Dyspnoea—Irinotecan—colon cancer	0.000145	0.00205	CcSEcCtD
Triamcinolone—Fatigue—Vincristine—colon cancer	0.000144	0.00204	CcSEcCtD
Triamcinolone—Dyspepsia—Irinotecan—colon cancer	0.000143	0.00203	CcSEcCtD
Triamcinolone—Pain—Vincristine—colon cancer	0.000143	0.00202	CcSEcCtD
Triamcinolone—Asthma—Methotrexate—colon cancer	0.000143	0.00202	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000142	0.00201	CcSEcCtD
Triamcinolone—Insomnia—Fluorouracil—colon cancer	0.000141	0.00199	CcSEcCtD
Triamcinolone—Fatigue—Irinotecan—colon cancer	0.000141	0.00199	CcSEcCtD
Triamcinolone—Paraesthesia—Fluorouracil—colon cancer	0.00014	0.00198	CcSEcCtD
Triamcinolone—Pancreatitis—Methotrexate—colon cancer	0.00014	0.00198	CcSEcCtD
Triamcinolone—Pain—Irinotecan—colon cancer	0.000139	0.00197	CcSEcCtD
Triamcinolone—Dyspnoea—Fluorouracil—colon cancer	0.000139	0.00197	CcSEcCtD
Triamcinolone—Dyspepsia—Fluorouracil—colon cancer	0.000137	0.00194	CcSEcCtD
Triamcinolone—Arrhythmia—Capecitabine—colon cancer	0.000137	0.00194	CcSEcCtD
Triamcinolone—Feeling abnormal—Irinotecan—colon cancer	0.000134	0.0019	CcSEcCtD
Triamcinolone—Erythema—Capecitabine—colon cancer	0.000134	0.00189	CcSEcCtD
Triamcinolone—Pain—Fluorouracil—colon cancer	0.000133	0.00189	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Methotrexate—colon cancer	0.000133	0.00188	CcSEcCtD
Triamcinolone—Body temperature increased—Vincristine—colon cancer	0.000132	0.00187	CcSEcCtD
Triamcinolone—Dysgeusia—Capecitabine—colon cancer	0.000131	0.00185	CcSEcCtD
Triamcinolone—Back pain—Capecitabine—colon cancer	0.000129	0.00183	CcSEcCtD
Triamcinolone—Body temperature increased—Irinotecan—colon cancer	0.000129	0.00182	CcSEcCtD
Triamcinolone—PTGS2—lymph node—colon cancer	0.000129	0.0119	CbGeAlD
Triamcinolone—Feeling abnormal—Fluorouracil—colon cancer	0.000129	0.00182	CcSEcCtD
Triamcinolone—Ill-defined disorder—Capecitabine—colon cancer	0.000124	0.00175	CcSEcCtD
Triamcinolone—Urticaria—Fluorouracil—colon cancer	0.000124	0.00175	CcSEcCtD
Triamcinolone—Conjunctivitis—Methotrexate—colon cancer	0.000124	0.00175	CcSEcCtD
Triamcinolone—Body temperature increased—Fluorouracil—colon cancer	0.000123	0.00174	CcSEcCtD
Triamcinolone—Hypersensitivity—Vincristine—colon cancer	0.000123	0.00174	CcSEcCtD
Triamcinolone—Malaise—Capecitabine—colon cancer	0.000121	0.0017	CcSEcCtD
Triamcinolone—Methylprednisolone—ABCB1—colon cancer	0.00012	0.151	CrCbGaD
Triamcinolone—Epistaxis—Methotrexate—colon cancer	0.00012	0.0017	CcSEcCtD
Triamcinolone—Vertigo—Capecitabine—colon cancer	0.00012	0.0017	CcSEcCtD
Triamcinolone—Hypersensitivity—Irinotecan—colon cancer	0.00012	0.0017	CcSEcCtD
Triamcinolone—Asthenia—Vincristine—colon cancer	0.00012	0.0017	CcSEcCtD
Triamcinolone—Syncope—Capecitabine—colon cancer	0.00012	0.00169	CcSEcCtD
Triamcinolone—Loss of consciousness—Capecitabine—colon cancer	0.000117	0.00166	CcSEcCtD
Triamcinolone—Asthenia—Irinotecan—colon cancer	0.000117	0.00165	CcSEcCtD
Triamcinolone—Cough—Capecitabine—colon cancer	0.000117	0.00165	CcSEcCtD
Triamcinolone—Hypertension—Capecitabine—colon cancer	0.000115	0.00163	CcSEcCtD
Triamcinolone—Hypersensitivity—Fluorouracil—colon cancer	0.000115	0.00162	CcSEcCtD
Triamcinolone—Haemoglobin—Methotrexate—colon cancer	0.000115	0.00162	CcSEcCtD
Triamcinolone—Haemorrhage—Methotrexate—colon cancer	0.000114	0.00161	CcSEcCtD
Triamcinolone—Myalgia—Capecitabine—colon cancer	0.000114	0.00161	CcSEcCtD
Triamcinolone—Pharyngitis—Methotrexate—colon cancer	0.000113	0.0016	CcSEcCtD
Triamcinolone—Discomfort—Capecitabine—colon cancer	0.000112	0.00159	CcSEcCtD
Triamcinolone—Dry mouth—Capecitabine—colon cancer	0.000111	0.00157	CcSEcCtD
Triamcinolone—Dizziness—Vincristine—colon cancer	0.000111	0.00156	CcSEcCtD
Triamcinolone—Pruritus—Fluorouracil—colon cancer	0.00011	0.00156	CcSEcCtD
Triamcinolone—Oedema—Capecitabine—colon cancer	0.000109	0.00154	CcSEcCtD
Triamcinolone—Infection—Capecitabine—colon cancer	0.000108	0.00153	CcSEcCtD
Triamcinolone—Dizziness—Irinotecan—colon cancer	0.000108	0.00152	CcSEcCtD
Triamcinolone—Shock—Capecitabine—colon cancer	0.000107	0.00152	CcSEcCtD
Triamcinolone—Tachycardia—Capecitabine—colon cancer	0.000106	0.0015	CcSEcCtD
Triamcinolone—Vomiting—Vincristine—colon cancer	0.000106	0.0015	CcSEcCtD
Triamcinolone—Rash—Vincristine—colon cancer	0.000106	0.00149	CcSEcCtD
Triamcinolone—Hyperhidrosis—Capecitabine—colon cancer	0.000105	0.00149	CcSEcCtD
Triamcinolone—Dermatitis—Vincristine—colon cancer	0.000105	0.00149	CcSEcCtD
Triamcinolone—Headache—Vincristine—colon cancer	0.000105	0.00148	CcSEcCtD
Triamcinolone—Vomiting—Irinotecan—colon cancer	0.000104	0.00146	CcSEcCtD
Triamcinolone—Dizziness—Fluorouracil—colon cancer	0.000103	0.00146	CcSEcCtD
Triamcinolone—Rash—Irinotecan—colon cancer	0.000103	0.00145	CcSEcCtD
Triamcinolone—Dermatitis—Irinotecan—colon cancer	0.000103	0.00145	CcSEcCtD
Triamcinolone—Headache—Irinotecan—colon cancer	0.000102	0.00144	CcSEcCtD
Triamcinolone—Erythema—Methotrexate—colon cancer	9.95e-05	0.00141	CcSEcCtD
Triamcinolone—Nausea—Vincristine—colon cancer	9.94e-05	0.0014	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Capecitabine—colon cancer	9.94e-05	0.0014	CcSEcCtD
Triamcinolone—Vomiting—Fluorouracil—colon cancer	9.93e-05	0.0014	CcSEcCtD
Triamcinolone—Insomnia—Capecitabine—colon cancer	9.87e-05	0.00139	CcSEcCtD
Triamcinolone—Rash—Fluorouracil—colon cancer	9.84e-05	0.00139	CcSEcCtD
Triamcinolone—Dermatitis—Fluorouracil—colon cancer	9.83e-05	0.00139	CcSEcCtD
Triamcinolone—Paraesthesia—Capecitabine—colon cancer	9.8e-05	0.00138	CcSEcCtD
Triamcinolone—Headache—Fluorouracil—colon cancer	9.78e-05	0.00138	CcSEcCtD
Triamcinolone—Betamethasone—PTGS2—colon cancer	9.77e-05	0.122	CrCbGaD
Triamcinolone—Dysgeusia—Methotrexate—colon cancer	9.74e-05	0.00138	CcSEcCtD
Triamcinolone—Dyspnoea—Capecitabine—colon cancer	9.73e-05	0.00137	CcSEcCtD
Triamcinolone—Nausea—Irinotecan—colon cancer	9.68e-05	0.00137	CcSEcCtD
Triamcinolone—Back pain—Methotrexate—colon cancer	9.62e-05	0.00136	CcSEcCtD
Triamcinolone—Dyspepsia—Capecitabine—colon cancer	9.6e-05	0.00136	CcSEcCtD
Triamcinolone—Fatigue—Capecitabine—colon cancer	9.4e-05	0.00133	CcSEcCtD
Triamcinolone—Pain—Capecitabine—colon cancer	9.33e-05	0.00132	CcSEcCtD
Triamcinolone—Nausea—Fluorouracil—colon cancer	9.27e-05	0.00131	CcSEcCtD
Triamcinolone—Ill-defined disorder—Methotrexate—colon cancer	9.23e-05	0.0013	CcSEcCtD
Triamcinolone—Prednisone—ABCB1—colon cancer	9.2e-05	0.115	CrCbGaD
Triamcinolone—Feeling abnormal—Capecitabine—colon cancer	8.99e-05	0.00127	CcSEcCtD
Triamcinolone—Malaise—Methotrexate—colon cancer	8.97e-05	0.00127	CcSEcCtD
Triamcinolone—Vertigo—Methotrexate—colon cancer	8.94e-05	0.00126	CcSEcCtD
Triamcinolone—Cough—Methotrexate—colon cancer	8.68e-05	0.00123	CcSEcCtD
Triamcinolone—Urticaria—Capecitabine—colon cancer	8.67e-05	0.00122	CcSEcCtD
Triamcinolone—Body temperature increased—Capecitabine—colon cancer	8.62e-05	0.00122	CcSEcCtD
Triamcinolone—Convulsion—Methotrexate—colon cancer	8.62e-05	0.00122	CcSEcCtD
Triamcinolone—Prednisolone—ABCB1—colon cancer	8.48e-05	0.106	CrCbGaD
Triamcinolone—Myalgia—Methotrexate—colon cancer	8.47e-05	0.0012	CcSEcCtD
Triamcinolone—Discomfort—Methotrexate—colon cancer	8.37e-05	0.00118	CcSEcCtD
Triamcinolone—Betamethasone—ABCB1—colon cancer	8.31e-05	0.104	CrCbGaD
Triamcinolone—Anaphylactic shock—Methotrexate—colon cancer	8.12e-05	0.00115	CcSEcCtD
Triamcinolone—Infection—Methotrexate—colon cancer	8.07e-05	0.00114	CcSEcCtD
Triamcinolone—Hypersensitivity—Capecitabine—colon cancer	8.04e-05	0.00114	CcSEcCtD
Triamcinolone—Hyperhidrosis—Methotrexate—colon cancer	7.85e-05	0.00111	CcSEcCtD
Triamcinolone—Asthenia—Capecitabine—colon cancer	7.83e-05	0.00111	CcSEcCtD
Triamcinolone—Pruritus—Capecitabine—colon cancer	7.72e-05	0.00109	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Methotrexate—colon cancer	7.4e-05	0.00105	CcSEcCtD
Triamcinolone—Insomnia—Methotrexate—colon cancer	7.34e-05	0.00104	CcSEcCtD
Triamcinolone—Paraesthesia—Methotrexate—colon cancer	7.29e-05	0.00103	CcSEcCtD
Triamcinolone—Dyspnoea—Methotrexate—colon cancer	7.24e-05	0.00102	CcSEcCtD
Triamcinolone—Dizziness—Capecitabine—colon cancer	7.21e-05	0.00102	CcSEcCtD
Triamcinolone—Dyspepsia—Methotrexate—colon cancer	7.15e-05	0.00101	CcSEcCtD
Triamcinolone—Fatigue—Methotrexate—colon cancer	7e-05	0.000989	CcSEcCtD
Triamcinolone—Pain—Methotrexate—colon cancer	6.94e-05	0.000981	CcSEcCtD
Triamcinolone—Vomiting—Capecitabine—colon cancer	6.94e-05	0.00098	CcSEcCtD
Triamcinolone—Rash—Capecitabine—colon cancer	6.88e-05	0.000972	CcSEcCtD
Triamcinolone—Dermatitis—Capecitabine—colon cancer	6.87e-05	0.000971	CcSEcCtD
Triamcinolone—Headache—Capecitabine—colon cancer	6.83e-05	0.000966	CcSEcCtD
Triamcinolone—Feeling abnormal—Methotrexate—colon cancer	6.69e-05	0.000945	CcSEcCtD
Triamcinolone—Hydrocortisone—ABCB1—colon cancer	6.49e-05	0.0812	CrCbGaD
Triamcinolone—Nausea—Capecitabine—colon cancer	6.48e-05	0.000915	CcSEcCtD
Triamcinolone—Urticaria—Methotrexate—colon cancer	6.45e-05	0.000911	CcSEcCtD
Triamcinolone—Body temperature increased—Methotrexate—colon cancer	6.42e-05	0.000907	CcSEcCtD
Triamcinolone—Hypersensitivity—Methotrexate—colon cancer	5.98e-05	0.000845	CcSEcCtD
Triamcinolone—Asthenia—Methotrexate—colon cancer	5.83e-05	0.000823	CcSEcCtD
Triamcinolone—Pruritus—Methotrexate—colon cancer	5.75e-05	0.000812	CcSEcCtD
Triamcinolone—Dexamethasone—PTGS2—colon cancer	5.68e-05	0.0712	CrCbGaD
Triamcinolone—Dizziness—Methotrexate—colon cancer	5.37e-05	0.000759	CcSEcCtD
Triamcinolone—Vomiting—Methotrexate—colon cancer	5.16e-05	0.000729	CcSEcCtD
Triamcinolone—Rash—Methotrexate—colon cancer	5.12e-05	0.000723	CcSEcCtD
Triamcinolone—Dermatitis—Methotrexate—colon cancer	5.12e-05	0.000723	CcSEcCtD
Triamcinolone—Headache—Methotrexate—colon cancer	5.09e-05	0.000719	CcSEcCtD
Triamcinolone—Dexamethasone—ABCB1—colon cancer	4.83e-05	0.0605	CrCbGaD
Triamcinolone—Nausea—Methotrexate—colon cancer	4.82e-05	0.000681	CcSEcCtD
